Very small individuals (under 50kg) might start at the lower end of dose ranges
Its strongest preclinical evidence is in tendon and ligament healing, gastrointestinal ulcer protection, and inflammatory bowel conditions
GHK-Cu is a cosmetic peptide known for supporting skin and scalp appearance, not a drug or FDA-approved treatment for hair loss
For research purposes only
A 2020 study measuring cord blood biomarkers found dose-response relationships: children with highest cord blood levels of NAPQI-related metabolites faced 2-3x higher odds of attention/focus disorder
doi: 10.3389/fphar.2026.1844144 Received 31 March 2026 Revised 26 June 2026 Accepted 29 June 2026 Published 27 July 2026 Volume 17 - 2026 Edited by Qingbin Cui, University of Toledo College of Medicine and Life Sciences, United States Reviewed by Kaushik Neogi, Deemed to be University, India Long Wu, Wuhan University, China Updates Copyright 2026 Lofaro, Ferri, Mazzilli, Bonacorsi, Simonini and Boraldi